Fibrinolytic Agents Concept

subject area of

• "2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19": reply.  Journal Articles
• 14 Antithrombotic treatment of cerebrovascular disease  Journal Articles
• 15 Side-effects of antithrombotic therapy  Journal Articles
• 2 Mechanisms of action of low molecular weight heparins and heparinoids  Journal Articles
• 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Journal Articles
• 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis  Journal Articles
• 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Journal Articles
• 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19  Journal Articles
• 6 Mechanism of action of the thrombolytic agents  Journal Articles
• In‐Vitro Studies with Ancrod (‘Arvin’)  Journal Articles
• A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease  Journal Articles
• A Five-Year Study of Intrapleural Fibrinolytic Therapy in Loculated Pleural Collections.  Journal Articles
• A Histomorphometric Comparison of the Effects of Heparin and Low-Molecular-Weight Heparin on Cancellous Bone in Rats  Journal Articles
• A Histomorphometric Evaluation of Heparin-Induced Bone Loss After Discontinuation of Heparin Treatment in Rats  Journal Articles
• A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke  Journal Articles
• A National Canadian Survey of Antithrombotic Therapy After Urgent and Emergent Limb Revascularization  Journal Articles
• A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation  Journal Articles
• A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis  Journal Articles
• A Pooled Analysis of Diffusion-Weighted Imaging Lesions in Patients With Acute Intracerebral Hemorrhage  Journal Articles
• A Survey of the Use of Empiric Novel Anticoagulants During Investigation of Stroke  Journal Articles
• A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement  Journal Articles
• A comparison of practice patterns for acute myocardial infarction between hospitals in Canada and India.  Journal Articles
• A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID‐19  Journal Articles
• A guide to GRADE guidelines for the readers of JTH  Journal Articles
• A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo  Journal Articles
• A novel approach to thrombin inhibition  Journal Articles
• A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)  Journal Articles
• A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer  Journal Articles
• A randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643]  Journal Articles
• ABC of antithrombotic therapy: Valvar heart disease and prosthetic heart valves  Journal Articles
• Accelerated Infusion of Streptokinase for the Treatment of Left-Sided Prosthetic Valve Thrombosis  Journal Articles
• Acute Ischemic Stroke Therapy Overview  Journal Articles
• Acute coronary syndromes without ST segment elevation  Journal Articles
• Acute stroke management.  Journal Articles
• Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process  Journal Articles
• Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation  Journal Articles
• Adjunctive Use of Direct Thrombin Inhibitors in Patients Receiving Fibrinolytic Therapy for Acute Myocardial Infarction  Journal Articles
• Advances in Antithrombotic Therapy  Journal Articles
• Advances in Antithrombotic Therapy: Novel Agents  Journal Articles
• Advances in antithrombotic drug therapy for coronary artery disease  Journal Articles
• After PCI in AF, dual antithrombotic therapy with dabigatran reduced bleeding compared with triple therapy  Journal Articles
• American College of Chest Physicians Guidelines for Heparin-Induced Thrombocytopenia: Response  Journal Articles
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy  Journal Articles
• An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: A meta-analysis of contemporary randomized controlled trials  Journal Articles
• Animal Models of Thrombosis From Zebrafish to Nonhuman Primates  Journal Articles
• Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial  Journal Articles
• Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?  Journal Articles
• Anticoagulants in acute coronary syndromes  Journal Articles
• Anticoagulation for prosthetic heart valves  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation therapy in patients with prosthetic heart valves.  Journal Articles
• Antiphospholipid antibodies in critical illness  Journal Articles
• Antiphospholipid antibody syndrome  Journal Articles
• Antithrombin-Heparin Covalent Complex  Journal Articles
• Antithrombotic Agents in Coronary Artery Disease  Journal Articles
• Antithrombotic Agents in Coronary Artery Disease  Journal Articles
• Antithrombotic Drugs  Journal Articles
• Antithrombotic Drugs  Journal Articles
• Antithrombotic Management After Transcatheter Aortic Valve Replacement: A Survey of Canadian Physicians  Journal Articles
• Antithrombotic Strategies for Patients With Peripheral Artery Disease: JACC Scientific Statement.  Journal Articles
• Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation  Journal Articles
• Antithrombotic Therapy During Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic Therapy Following Heart Valve Replacement  Journal Articles
• Antithrombotic Therapy and Invasive Procedures  Journal Articles
• Antithrombotic Therapy for Atrial Fibrillation  Journal Articles
• Antithrombotic Therapy for Cerebrovascular Disorders  Journal Articles
• Antithrombotic Therapy for Coronary Artery Disease  Journal Articles
• Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes  Journal Articles
• Antithrombotic Therapy for Peripheral Artery Disease  Journal Articles
• Antithrombotic Therapy in Children*  Journal Articles
• Antithrombotic Therapy in Neonates and Children  Journal Articles
• Antithrombotic Therapy in Neonates and Children  Journal Articles
• Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty  Journal Articles
• Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty  Journal Articles
• Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Journal Articles
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Journal Articles
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Journal Articles
• Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts  Journal Articles
• Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts  Journal Articles
• Antithrombotic Therapy in Peripheral Artery Disease: Risk Stratification and Clinical Decision Making  Journal Articles
• Antithrombotic Treatment of Splanchnic Vein Thrombosis: Results of an International Registry  Journal Articles
• Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses  Journal Articles
• Antithrombotic and Thrombolytic Therapy  Journal Articles
• Antithrombotic and Thrombolytic Therapy for Valvular Disease  Journal Articles
• Antithrombotic and Thrombolytic Therapy: From Evidence to Application  Journal Articles
• Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Journal Articles
• Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands - The EXAMINE-AF study. A questionnaire survey  Journal Articles
• Antithrombotic drug removal from whole blood using Haemoadsorption with a porous polymer bead sorbent  Journal Articles
• Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events  Journal Articles
• Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding  Journal Articles
• Antithrombotic management of patients with deep vein thrombosis and venous stents: an international registry  Journal Articles
• Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends  Journal Articles
• Antithrombotic therapies in Canadian atrial fibrillation patients with concomitant coronary artery disease: Insights from the CONNECT AF + PCI-II program  Journal Articles
• Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report  Journal Articles
• Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Journal Articles
• Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents  Journal Articles
• Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves  Journal Articles
• Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation  Journal Articles
• Antithrombotic therapy in aortic diseases: A narrative review  Journal Articles
• Antithrombotic therapy in atrial fibrillation.  Journal Articles
• Antithrombotic therapy in children with venous thromboembolism  Journal Articles
• Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Journal Articles
• Antithrombotic therapy in the management of hospitalised patients with COVID-19  Journal Articles
• Antithrombotic therapy: the expanding role of low molecular weight heparin.  Journal Articles
• Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis  Journal Articles
• Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation  Journal Articles
• Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme  Journal Articles
• Antithrombotic treatment for peripheral arterial disease  Journal Articles
• Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation  Journal Articles
• Antithrombotics and Anticoagulants in Coronary Syndromes and Stroke  Journal Articles
• Antithrombotics in stable peripheral artery disease  Journal Articles
• Apixaban for Extended Treatment of Venous Thromboembolism  Journal Articles
• Apixaban in Patients with Atrial Fibrillation  Journal Articles
• Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial  Journal Articles
• Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial  Journal Articles
• Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen  Journal Articles
• Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease  Journal Articles
• Applying new strategies for the national adaptation, updating, and dissemination of trustworthy guidelines: results from the Norwegian adaptation of the antithrombotic therapy and the prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Journal Articles
• Applying the Grades of Recommendation for Antithrombotic and Thrombolytic Therapy  Journal Articles
• Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Journal Articles
• Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation  Journal Articles
• Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.  Journal Articles
• Are Asymptomatic DVTs Relevant?: Response  Journal Articles
• Aspirin Use and Risk of Subdural Hematoma: Updated Meta-Analysis of Randomized Trials  Journal Articles
• Aspirin in coronary artery surgery: 1-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery trial  Journal Articles
• Aspirin resistance:a new independent predictor of vascular events?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do no necessarily represent the views of JACCor the American College of Cardiology.  Journal Articles
• Assessment of antithrombotic drugs ex vivo and in vivo.  Journal Articles
• Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH  Journal Articles
• BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 receptor and phosphodiesterase  Journal Articles
• Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia  Journal Articles
• Beyond Heparin and Aspirin  Journal Articles
• Beyond Unfractionated Heparin and Warfarin  Journal Articles
• Bivalirudin  Journal Articles
• Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin  Journal Articles
• Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency  Journal Articles
• Bleeding associated with antithrombotic therapy.  Journal Articles
• Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology  Journal Articles
• Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta‐analysis  Journal Articles
• Bolus, front-loaded, and accelerated thrombolytic infusions for myocardial infarction and pulmonary embolism.  Journal Articles
• Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism  Journal Articles
• COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up  Journal Articles
• Can we optimise treatment of thrombosis?  Journal Articles
• Canadian Consensus Conference on Coronary Thrombolysis--1994 update.  Journal Articles
• Cancer and Tumor-Associated Childhood Stroke: Results From the International Pediatric Stroke Study  Journal Articles
• Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE  Journal Articles
• Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease  Journal Articles
• Catalysis of Thrombin Inhibition Provides an Index for Estimating the Antithrombotic Potential of Glycosaminoglycans in Rabbits  Journal Articles
• Catheter-directed thrombolysis for extensive iliofemoral deep vein thrombosis: review of literature and ongoing trials  Journal Articles
• Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke  Journal Articles
• Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk  Journal Articles
• Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation  Journal Articles
• Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial  Journal Articles
• Characterization of the Interactions of Plasminogen and Tissue and Vampire Bat Plasminogen Activators with Fibrinogen, Fibrin, and the Complex of d-Dimer Noncovalently Linked to Fragment E  Journal Articles
• Chemical–Physical Characterization of Polyurethane Catheters Modified with a Novel Antithrombin-Heparin Covalent Complex  Journal Articles
• Chills and limb pain following administration of low‐molecular‐weight heparin for treatment of acute venous thromboembolism  Journal Articles
• Choice of low molecular weight heparins  Journal Articles
• Choice of low molecular weight heparins.  Journal Articles
• Clinical Recommendations Using Levels of Evidence for Antithrombotic Agents  Journal Articles
• Clinical Relevance of Bleeding Index  Journal Articles
• Clinical Studies with Anticoagulants that Have Changed Clinical Practice  Journal Articles
• Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin‐induced thrombocytopenia  Journal Articles
• Clinical outcomes following early versus late pharmacologic thromboprophylaxis in patients with traumatic intracranial hemorrhage: a systematic review and meta-analysis  Journal Articles
• Clinical potential of antithrombotic drugs in coronary syndromes  Journal Articles
• Clinical prognosis, pre-existing conditions and the use of reperfusion therapy for patients with ST segment elevation acute myocardial infarction  Journal Articles
• Clinical relevance of bleeding index - In reply  Journal Articles
• Colchicine pre-treatment and post-treatment does not worsen bleeding or functional outcome after collagenase-induced intracerebral hemorrhage  Journal Articles
• Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS)  Journal Articles
• Combination Antithrombotic Therapy for Reduction of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease.  Conferences
• Combined administration of barbourin–albumin and hirudin–albumin fusion proteins limits fibrin(ogen) deposition on the rabbit balloon-injured aorta  Journal Articles
• Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?  Journal Articles
• Combining Early Ischemic Change and Collateral Extent for Functional Outcomes After Endovascular Therapy: An Analysis From AcT Trial  Journal Articles
• Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?  Journal Articles
• Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition  Journal Articles
• Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis  Conferences
• Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)  Journal Articles
• Comparison of the Effects of Two Doses of Recombinant Hirudin Compared With Heparin in Patients With Acute Myocardial Ischemia Without ST Elevation  Journal Articles
• Comparison of the Efficacy of Pharmacoinvasive Management for ST-Segment Elevation Myocardial Infarction in Smokers Versus Non-Smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction)  Journal Articles
• Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism  Journal Articles
• Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-iii affinity heparin fraction  Journal Articles
• Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis  Conferences
• Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.  Journal Articles
• Consent-Related Outcomes in the Alteplase Compared to Tenecteplase Trial.  Journal Articles
• Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: a descriptive study  Journal Articles
• Consultative Hematology: The Pregnant Patient Pregnancy Loss  Journal Articles
• Correlation of Plasma Coagulation Parameters With Thromboprophylaxis, Patient Characteristics, and Outcome in the MEDENOX Study  Journal Articles
• Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis  Journal Articles
• Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist  Journal Articles
• Cumulating evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysis  Journal Articles
• Current use of biologicals in thrombosis and haemostasis  Journal Articles
• DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE  Journal Articles
• Dabigatran Etexilate: Future Directions in Anticoagulant Treatment  Journal Articles
• Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial  Journal Articles
• Dabigatran-related coagulopathy: when can we assume the effect has “worn off”?  Journal Articles
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients  Journal Articles
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients  Journal Articles
• Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective  Journal Articles
• Delayed‐onset HIT caused by low‐molecular‐weight heparin manifesting during fondaparinux prophylaxis  Journal Articles
• Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes–2 (OASIS–2) trial  Journal Articles
• Determinants of Bleeding Risk in Patients on Antithrombotic and Antifibrinolytic Drugs  Journal Articles
• Developing a novel antithrombotic in the academic environment  Journal Articles
• Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines  Journal Articles
• Development and validation of a decision aid for choosing among antithrombotic agents for atrial fibrillation  Journal Articles
• Diagnosis and Treatment of Venous Thromboembolism  Journal Articles
• Diagnosis of DVT  Journal Articles
• Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet‐mediated events during thrombus formation  Journal Articles
• Direct Thrombin Inhibitors in Cardiac Disease  Journal Articles
• Direct oral anticoagulants versus vitamin K antagonists in the first 3 months after bioprosthetic valve replacement: a systematic review and meta-analysis  Journal Articles
• Direct thrombin inhibitors  Journal Articles
• Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin  Conferences
• Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)?  Journal Articles
• Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction?  Journal Articles
• Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?  Journal Articles
• Dose Antiplatelet Agents; The Relationship Among Side Effects, and Antithrombotic Effectiveness  Journal Articles
• Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic events  Journal Articles
• Dose–response study of recombinant human soluble thrombomodulin (ART‐123) in the prevention of venous thromboembolism after total hip replacement  Journal Articles
• Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions  Journal Articles
• Dual and triple antithrombotic therapies: current patterns of practice and controversies  Journal Articles
• Dual antithrombotic treatment in chronic coronary syndrome: European Society of Cardiology criteria vs. CHADS-P2A2RC score  Journal Articles
• Dual surface modification of polydimethylsiloxane (PDMS) with antithrombin-heparin complex (ATH) and tissue plasminogen activator (t-PA) for enhanced antithrombotic activity.  Journal Articles
• Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease  Journal Articles
• Duration of primary/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis.  Journal Articles
• ESSENCE trial results: breaking new ground. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events.  Journal Articles
• Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial  Journal Articles
• Economic issues in glycoprotein IIb/IIIa receptor therapy  Journal Articles
• Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina with Aggrastat® [tirofiban] and Determine Cost of Therapy with Invasive or Conservative Strategy)–TIMI 18 trial  Journal Articles
• Effect of Aspirin on Hemostasis and Thrombosis  Journal Articles
• Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke  Journal Articles
• Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis Model  Journal Articles
• Effect of Reversal of Neuromuscular Blockade with Sugammadex versus Usual Care on Bleeding Risk in a Randomized Study of Surgical Patients  Journal Articles
• Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial  Journal Articles
• Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi in rabbits.  Journal Articles
• Effect of thrombolysis type on the efficacy of aspiration versus stent retriever first line thrombectomy: results from the AcT trial.  Journal Articles
• Effective, selective and specific inhibition of COX-1 may overcome the “aspirin paradox”  Journal Articles
• Effectiveness and safety of abciximab after failed thrombolytic therapy  Journal Articles
• Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema  Journal Articles
• Effects of Sulfated Polysaccharides on Inhibition of Thrombus Formation initiated by Different Stimuli  Journal Articles
• Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial  Journal Articles
• Efficacy and Safety of a Routine Early Invasive Strategy in Relation to Time from Symptom Onset to Fibrinolysis (a Subgroup Analysis of TRANSFER-AMI)  Journal Articles
• Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial  Journal Articles
• Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial  Journal Articles
• Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves  Journal Articles
• Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial.  Journal Articles
• Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER^®, RE-COVER™ II, and RE-MEDY™  Journal Articles
• Emergence of the Primary Pediatric Stroke Center  Journal Articles
• Endovascular Thrombectomy for Acute Ischemic Stroke  Journal Articles
• Endovascular thrombectomy and intravenous alteplase in patients with acute ischemic stroke due to large vessel occlusion: A clinical practice guideline  Journal Articles
• Enhancement of the Activity of Optimum Concentrations of Urokinase by the Venom of Echis carinata  Journal Articles
• Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction  Journal Articles
• Evaluating compliance of extended venous thromboembolism prophylaxis following abdominopelvic surgery for cancer: A multidisciplinary quality improvement project  Journal Articles
• Evaluation of the use of venous thromboembolism prophylaxis in hospitalised medical patients  Journal Articles
• Evidence-Based Management of Anticoagulant Therapy  Journal Articles
• Evidence-based postoperative replantation protocols.  Journal Articles
• Evidence-based treatment of the antiphospholipid syndrome  Journal Articles
• Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation  Journal Articles
• Executive Summary  Journal Articles
• Executive summary: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Journal Articles
• Extended perioperative thromboprophylaxis in patients with cancer  Journal Articles
• Extended perioperative thromboprophylaxis in patients with cancer. A systematic review.  Journal Articles
• Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery – the SAVE-HIP3 study  Journal Articles
• Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trials  Journal Articles
• External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry  Journal Articles
• External applicability of the COMPASS trial: the Western Denmark Heart Registry  Journal Articles
• External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR)  Journal Articles
• Factors Influencing Nerinetide Effect on Infarct Volume in Patients Without Alteplase in the Randomized ESCAPE-NA1 Trial.  Journal Articles
• Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards  Journal Articles
• Factors at Admission Associated With Bleeding Risk in Medical Patients  Journal Articles
• Failure of Aspirin to Prevent Atherothrombosis  Journal Articles
• Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists  Journal Articles
• Fibrinolysis: strategies to enhance the treatment of acute ischemic stroke  Journal Articles
• Fibrinolytic Poly(dimethyl siloxane) Surfaces  Journal Articles
• Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study  Journal Articles
• Fifty years of research on antithrombotic therapy: Achievements and disappointments  Journal Articles
• Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery  Journal Articles
• Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery  Journal Articles
• Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery  Journal Articles
• Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.  Journal Articles
• Fondaparinux versus enoxaparin for prevention of venous thromboembolism  Journal Articles
• Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic Surgery<subtitle>A Meta-analysis of 4 Randomized Double-blind Studies</subtitle>  Journal Articles
• Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy  Journal Articles
• Formatting modifications in GRADE evidence profiles improved guideline panelists comprehension and accessibility to information. A randomized trial  Journal Articles
• Further Studies on the Mechanisms for the Antithrombotic Effects of Sulfated Polysaccharides in Rabbits  Journal Articles
• GASTROINTESTINAL BLEEDING AFTER ACUTE ISCHEMIC STROKE  Journal Articles
• Getting intimate with the venous thrombus  Journal Articles
• Global Survey of the Diagnostic Evaluation and Management of Cryptogenic Ischemic Stroke  Journal Articles
• Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals  Journal Articles
• Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH  Journal Articles
• Grades of Recommendation for Antithrombotic Agents  Journal Articles
• Grades of Recommendation for Antithrombotic Agents  Journal Articles
• Grades of Recommendation for Antithrombotic Agents  Journal Articles
• Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week  Journal Articles
• Guided Antithrombotic Therapy: Current Status and Future Research Direction  Journal Articles
• Guideline conflict of interest management and methodology heavily impacts on the strength of recommendations: comparison between two iterations of the American College of Chest Physicians Antithrombotic Guidelines  Journal Articles
• Guideline conflict of interest management and methodology heavily impacts on the strength of recommendations: comparison between two iterations of the American College of Chest Physicians Antithrombotic Guidelines.  Journal Articles
• Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation  Journal Articles
• Guidelines for Management of Left-Sided Prosthetic Valve Thrombosis: A Role for Thrombolytic Therapy 11These guidelines are the results of a Consensus Conference held during the Symposium on Prosthetic Valve Thrombosis on September 16, 1994, in Budapest, Hungary.  Journal Articles
• Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.  Journal Articles
• HEMORRHAGIC COMPLICATIONS OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL-INFARCTION AND VENOUS THROMBOEMBOLISM  Journal Articles
• Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism  Conferences
• Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism  Journal Articles
• Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism.  Journal Articles
• Heparan sulfate: Antithrombotic or not?  Journal Articles
• Heparin Cofactor II and Other Endogenous Factors in the Mediation of the Antithrombotic and Anticoagulant Effects of Heparin and Dermatan Sulfate  Journal Articles
• Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss  Journal Articles
• Heparin and Low-Molecular-Weight Heparin  Journal Articles
• Heparin and low molecular weight heparins as scaffolds for assembling antithrombin and serine proteases  Journal Articles
• Heparin-Induced Thrombocytopenia: A Ten-Year Retrospective  Journal Articles
• Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention  Journal Articles
• Heparin-induced thrombocytopenia.  Conferences
• How Did We Get Here? Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement: A Review  Journal Articles
• How can we reduce disagreement among guidelines for venous thromboembolism prevention?  Journal Articles
• INHIBITION OF THROMBIN BY HIRUDIN GENETICALLY FUSED TO WILD-TYPE OR MUTANT ANTITHROMBIN  Journal Articles
• ISTH guidelines for antithrombotic treatment in COVID‐19  Journal Articles
• Idiopathic gangrene in African children.  Journal Articles
• Immunospecific analysis of in vitro and ex vivo surface-immobilized protein complex  Journal Articles
• Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada  Journal Articles
• Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction  Journal Articles
• In acute ischemic stroke, early intraarterial treatment plus usual care improved functional independence  Journal Articles
• In intermediate-risk acute PE, tenecteplase plus heparin reduced hemodynamic decompensation but increased stroke.  Journal Articles
• In ischemic stroke, early intraarterial treatment plus alteplase improved reperfusion and functional outcome  Journal Articles
• In vitro analysis of the herbal compound Essiac.  Journal Articles
• In vivo activity of a new heparinoid  Journal Articles
• In vivo activity of a new heparinoid.  Journal Articles
• In-Hospital Delays for Acute Stroke Treatment Delivery During the COVID-19 Pandemic  Journal Articles
• Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children  Conferences
• Increasing Use of Single and Combination Medical Therapy in Patients Hospitalized for Acute Myocardial Infarction in the 21st Century<subtitle>A Multinational Perspective</subtitle>  Journal Articles
• Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes  Journal Articles
• Inhibition of arterial thrombosis and platelet function by nafazatrom  Journal Articles
• Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082  Journal Articles
• Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction  Journal Articles
• Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial  Journal Articles
• International Normalized Ratio Targets for Left-Sided Mechanical Valve Replacement  Journal Articles
• Interruption of Warfarin Anticoagulation for Dental Surgery: Response  Journal Articles
• Interventions that potentially limit myocardial infarct size: Overview of clinical trials  Journal Articles
• Intra-Arterial Thrombolysis vs. Standard Treatment or Intravenous Thrombolysis in Adults with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis  Journal Articles
• Intra-arterial Prourokinase for Acute Ischemic Stroke  Journal Articles
• Intracranial Aneurysm Rupture Following Intravenous Thrombolysis for Stroke  Journal Articles
• Intracranial Haemorrhage in Patients on Antithrombotics: Clinical Presentation and Determinants of Outcome in a Prospective Multicentric Study in Italian Emergency Departments  Journal Articles
• Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy  Journal Articles
• Intracranial haemorrhage with bolus thrombolytic agents  Journal Articles
• Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial  Journal Articles
• Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions  Journal Articles
• Intravenous alteplase versus tenecteplase in patients with acute posterior circulation strokes: A secondary analysis from the AcT randomized controlled trial.  Journal Articles
• Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial  Journal Articles
• Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial  Journal Articles
• Introduction to the ninth edition: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Journal Articles
• Invited Commentary  Journal Articles
• Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Still an open question  Journal Articles
• Left Atrial Appendage Occlusion Study (LAAOS): A randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention  Journal Articles
• Left Atrial Appendage Occlusion Study II (LAAOS II)  Journal Articles
• Limited Fibrin Specificity of Tissue-type Plasminogen Activator and Its Potential Link to Bleeding  Journal Articles
• Long-term Follow-up of the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)  Journal Articles
• Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation  Journal Articles
• Long-term outcomes after acute myocardial infarction in countries with different socioeconomic environments: an international prospective cohort study  Journal Articles
• Low anonymous voting compliance with the novel policy for managing conflicts of interest implemented in the 9th version of the American College of Chest Physicians antithrombotic guidelines  Journal Articles
• Low molecular weight heparins in the treatment of unstable angina.  Journal Articles
• Low rates of preventive practices in patients with peripheral vascular disease.  Journal Articles
• Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin  Journal Articles
• Low-Molecular-Weight Heparin versus Unfractionated Heparin for Unstable Coronary Disease  Journal Articles
• Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials  Journal Articles
• Lysine-PEG-modified polyurethane as a fibrinolytic surface: Effect of PEG chain length on protein interactions, platelet interactions and clot lysis  Journal Articles
• Lysine-derivatized polyurethane as a clot lysing surface: conversion of adsorbed plasminogen to plasmin and clot lysis in vitro  Journal Articles
• Making the transition from video-assisted thoracoscopic surgery to chest tube with fibrinolytics for empyema in children: Any change in outcomes?  Journal Articles
• Management Of Venous Thromboembolism: Optimization By Clinical Trials  Journal Articles
• Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B.  Journal Articles
• Management of antithrombotic therapy after gastrointestinal bleeding: A mixed methods study of health‐care providers  Journal Articles
• Management of bleeding in patients on antithrombotics: maintaining the balance between thrombosis and hemorrhage  Journal Articles
• Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis  Journal Articles
• Management of thromboembolic disease in cancer patients.  Journal Articles
• Management of unstable angina and myocardial infarction  Journal Articles
• Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score  Journal Articles
• Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides  Journal Articles
• Medical device‐induced thrombosis: what causes it and how can we prevent it?  Journal Articles
• Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention  Journal Articles
• Methodology for Antithrombotic and Thrombolytic Therapy Guideline Development  Journal Articles
• Methodology for Guideline Development for the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy  Journal Articles
• Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Journal Articles
• Mimicking the fibrinolytic system on material surfaces  Journal Articles
• Missed opportunities for the secondary prevention of cardiovascular disease in Canada  Journal Articles
• Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS ₂ and CHA ₂ DS ₂ -VASc Scores in Patients With Atrial Fibrillation  Journal Articles
• Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation  Journal Articles
• Monitoring Emerging Data From the COMPASS Trial of an Antithrombotic Agent  Journal Articles
• Mortality Benefit in the Compass Trial: is It Related to Superior Statistical Power Or Better Efficacy and safety?  Journal Articles
• Mortality and Prehospital Thrombolysis for Acute Myocardial Infarction  Journal Articles
• Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W  Journal Articles
• Multiple overlapping systematic reviews facilitate the origin of disputes: the case of thrombolytic therapy for pulmonary embolism  Journal Articles
• Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound  Journal Articles
• New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management  Conferences
• New Anticoagulant Drugs  Journal Articles
• New Anticoagulant Strategies  Journal Articles
• New Antithrombotic Agents  Journal Articles
• New Antithrombotic Drugs  Journal Articles
• New Antithrombotic Drugs  Journal Articles
• New Antithrombotic Drugs  Journal Articles
• New Antithrombotic Drugs: Potential for Use in Oncology  Journal Articles
• New Antithrombotics  Journal Articles
• New anticoagulants  Conferences
• New anticoagulants: Moving beyond the direct oral anticoagulants  Journal Articles
• New antithrombotic agents  Journal Articles
• New antithrombotic agents—insights from clinical trials  Journal Articles
• New oral anticoagulants in atrial fibrillation  Journal Articles
• Non-traumatic vascular emergencies: imaging and intervention in acute arterial conditions  Journal Articles
• Novel antithrombotic strategies for treatment of venous thromboembolism  Journal Articles
• Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation.  Journal Articles
• Observations in anticoagulant and thrombolytic therapy in pulmonary embolism  Journal Articles
• Omega-3 Fatty Acids and Markers of Thrombosis in Patients with Atrial Fibrillation  Journal Articles
• Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage  Journal Articles
• Optimization of Treatment for Venous Thromboembolism and Prevention of Recurrences  Journal Articles
• Optimization of treatment for venous thromboembolism and prevention of recurrences - Co-chairman's summary  Conferences
• Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease  Journal Articles
• Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement  Journal Articles
• Outcome Evaluation of Acute Ischemic Stroke Patients Treated with Endovascular Thrombectomy: A Single-Institution Experience in the Era of Randomized Controlled Trials  Journal Articles
• Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours  Journal Articles
• Overexpression of the Multidrug Resistance Protein-4 Transporter in Patients Undergoing Coronary Artery Bypass Graft Surgery  Journal Articles
• Overutilization and underutilization of thrombolysis in routine clinical practice∗∗Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.  Journal Articles
• Overview of the clinical results of pentasaccharide in major orthopedic surgery.  Journal Articles
• PLATELET SUPPRESSIVE THERAPY  Journal Articles
• PROPORTION OF PATIENTS WITH MACULAR HOLE SURGERY WHO WOULD HAVE BEEN FAVORABLE OCRIPLASMIN CANDIDATES  Journal Articles
• PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan  Journal Articles
• Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study  Journal Articles
• Parenteral Anticoagulants  Journal Articles
• Part 5: Acute Coronary Syndromes  Journal Articles
• Part 9: Acute Coronary Syndromes  Journal Articles
• Part 9: Acute Coronary Syndromes  Journal Articles
• Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study  Journal Articles
• Patent foramen ovale closure and medical therapy did not differ for recurrence after cryptogenic embolism  Journal Articles
• Patent foramen ovale closure and medical therapy did not differ for recurrence after cryptogenic stroke  Journal Articles
• Pathobiologic features and prevention of thrombotic complications associated with prosthetic heart valves: Fundamental principles and the contribution of platelets and thrombin  Journal Articles
• Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Journal Articles
• Patterns of Stroke Transfers and Identification of Predictors for Thrombectomy  Journal Articles
• Pediatric Stroke Initiatives and Preliminary Studies: What Is Known and What Is Needed?  Conferences
• Perioperative Aspirin for Prevention of Venous Thromboembolism  Journal Articles
• Perioperative Management of Anticoagulation  Journal Articles
• Perioperative Management of Antithrombotic Therapy  Journal Articles
• Perioperative Management of Antithrombotic Therapy  Journal Articles
• Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants  Journal Articles
• Perioperative management of antithrombotic therapy  Journal Articles
• Perioperative management of antithrombotic therapy: a case-based narrative review  Journal Articles
• Perioperative management of antithrombotic therapy: lifting the fog  Journal Articles
• Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy  Journal Articles
• Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery  Journal Articles
• Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH  Journal Articles
• Pharmacologic and compression therapies for postthrombotic syndrome: a systematic review of randomized controlled trials  Journal Articles
• Pharmacologic tools to reduce bleeding in surgery.  Journal Articles
• Pharmacological Actions of Sulodexide  Journal Articles
• Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research  Journal Articles
• Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral–Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial  Journal Articles
• Physician Approaches to Antithrombotic Therapies for Recently Symptomatic Carotid Stenosis.  Journal Articles
• Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis  Journal Articles
• Plaque Sealing With Drug-Eluting Stents Versus Medical Therapy for Treating Intermediate Non-Obstructive Saphenous Vein Graft Lesions: A Pooled Analysis of the VELETI and VELETI II Trials.  Journal Articles
• Plasmin accelerates platelet‐dependent prothrombinase formation without activating the platelets  Journal Articles
• Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor.  Journal Articles
• Platelet-Active Drugs  Journal Articles
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Journal Articles
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Journal Articles
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Journal Articles
• Platelet-active drugs : the relationships among dose, effectiveness, and side effects.  Journal Articles
• Platelet-active drugs: the relationships among dose, effectiveness, and side effects.  Journal Articles
• Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment  Journal Articles
• Postdischarge venous thromboembolic complications following pulmonary oncologic resection: An underdetected problem  Journal Articles
• Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial  Journal Articles
• Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison  Journal Articles
• Potential antidotes for reversal of old and new oral anticoagulants  Journal Articles
• Practical Model-Based Dose Finding in Early-Phase Clinical Trials  Journal Articles
• Pre Admission Antithrombotics are Associated with Improved Outcomes following Ischaemic Stroke: A Cohort from the Registry of the Canadian Stroke Network  Journal Articles
• Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study  Journal Articles
• Predicting tissue plasminogen activator use and success in in-center hemodialysis patients  Journal Articles
• Preoperative Enoxaparin Versus Postoperative Semuloparin Thromboprophylaxis in Major Abdominal Surgery  Journal Articles
• Pretreatment of Human Platelets with Plasmin Inhibits Responses toThrombin, but Potentiates Responses to Low Concentrations of Aggregating Agents, Including the Thrombin Receptor Activating Peptide, SFLLRN  Journal Articles
• Prevalence and risk of inappropriate dosing of direct oral anticoagulants in two Swiss atrial fibrillation registries  Journal Articles
• Preventing Thromboembolic Complications in Older Orthopaedic Surgery Patients  Journal Articles
• Prevention and treatment of venous thromboembolism during pregnancy  Journal Articles
• Prevention of Thrombus Growth by Antithrombin III-Dependent and Two Direct Thrombin Inhibitors in Rabbits: Implications for Antithrombotic Therapy  Journal Articles
• Prevention of VTE in Orthopedic Surgery Patients  Journal Articles
• Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Journal Articles
• Prevention of activation of blood coagulation during acute coronary ischemic syndromes beyond aspirin and heparin  Journal Articles
• Prevention of thrombosis in antiphospholipid syndrome  Journal Articles
• Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents  Journal Articles
• Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX‐2)  Journal Articles
• Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke  Journal Articles
• Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Journal Articles
• Prognostic Significance of Thrombocytopenia During Hirudin and Heparin Therapy in Acute Coronary Syndrome Without ST Elevation  Journal Articles
• Progress review: the relationship between dose of aspirin, side-effects and antithrombotic effectiveness.  Journal Articles
• Progressive, Fatal Thrombosis Associated With Heparin-Induced Thrombocytopenia After Cardiac Surgery Despite “Therapeutic” Anticoagulation With Argatroban: Potential Role for PTT and ACT Confounding  Journal Articles
• Protein‐Resistant and Fibrinolytic Polyurethane Surfaces  Journal Articles
• Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial  Journal Articles
• Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis  Journal Articles
• Randomized Comparison of Direct Thrombin Inhibition Versus Heparin in Conjunction With Fibrinolytic Therapy for Acute Myocardial Infarction: Results From the GUSTO-IIb Trial  Journal Articles
• Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure  Journal Articles
• Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: Results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis)  Journal Articles
• Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.  Journal Articles
• Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease - One-year results of the ESSENCE study  Journal Articles
• Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52.  Journal Articles
• Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment  Journal Articles
• Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention  Journal Articles
• Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)  Journal Articles
• Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)  Journal Articles
• Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial  Journal Articles
• Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19  Journal Articles
• Recommendations for prophylaxis of pregnancy‐related venous thromboembolism in carriers of inherited thrombophilia. Comment on the 2012 ACCP guidelines: a rebuttal  Journal Articles
• Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial  Journal Articles
• Reduction of Out-of-Hospital Symptomatic Venous Thromboembolism by Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Elective Hip Arthroplasty  Journal Articles
• Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins  Journal Articles
• Reflecting on Eight Editions of the American College of Chest Physicians Antithrombotic Guidelines  Journal Articles
• Regression Analysis with a Misclassified Covariate from a Current Status Observation Scheme  Journal Articles
• Relation of Factor V Leiden Genotype to Risk for Acute Deep Venous Thrombosis after Joint Replacement Surgery  Journal Articles
• Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin  Journal Articles
• Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors  Journal Articles
• Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial  Journal Articles
• Rescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction  Journal Articles
• Response by Chan and Weitz to Letter Regarding Article, “Antithrombotic Agents: New Directions in Antithrombotic Therapy”  Journal Articles
• Response to “Effect of Tissue Plasminogen Activator Dose and Interval on Stroke Severity”  Journal Articles
• Restarting antithrombotics after GI bleeding was linked to better outcomes in patients with AF  Journal Articles
• Reversal of anti-thrombin activity using protamine sulfate. Experience in a neonate with a 10-fold overdose of enoxaparin  Journal Articles
• Review: In pulmonary embolism, thrombolytic therapy reduces all-cause mortality but increases major bleeding  Journal Articles
• Reviparin in Acute Myocardial Infarction—Reply  Journal Articles
• Reviparin in acute myocardial infarction.  Journal Articles
• Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry  Journal Articles
• Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial  Journal Articles
• Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation  Journal Articles
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials  Journal Articles
• Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis  Journal Articles
• Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES  Journal Articles
• Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial  Journal Articles
• Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction  Journal Articles
• Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios  Journal Articles
• Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty  Journal Articles
• Rivaroxaban for thromboprophylaxis after orthopaedic surgery: Pooled analysis of two studies  Journal Articles
• Rivaroxaban with or without aspirin for prevention of cardiovascular disease  Journal Articles
• Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion  Journal Articles
• Rivaroxaban, in combination with low-dose aspirin, is associated with a reduction in proinflammatory and prothrombotic circulating vesicle signatures in patients with cardiovascular disease.  Journal Articles
• Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents  Journal Articles
• Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction  Journal Articles
• Routine heparin for patients with cancer? One answer, more questions  Journal Articles
• Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.  Journal Articles
• Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes  Journal Articles
• Rules of Evidence and Clinical Recommendations on the Use of Antithrombotic Agents  Journal Articles
• STATIN DRUGS AND DIETARY ISOPRENOIDS AS ANTITHROMBOTIC AGENTS  Journal Articles
• SUBOPTIMAL PREVENTIVE PRACTICES IN PATIENTS WITH CAROTID AND PERIPHERAL VASCULAR OCCLUSIVE DISEASE IN A TERTIARY REFERRAL SETTING  Journal Articles
• Safe bridging to warfarin in heparin-induced thrombocytopenia  Journal Articles
• Safety Outcomes in Meta-analyses of Phase 2 vs Phase 3 Randomized Trials  Journal Articles
• Safety and Efficacy of Intravenous Thrombolysis by Infarct Type in Patients with No Visible Occlusion: A Secondary Analysis of the AcT Trial.  Journal Articles
• Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke  Journal Articles
• Safety and efficacy of tenecteplase versus alteplase in stroke patients with carotid tandem lesions: Results from the AcT trial  Journal Articles
• Safety of Bolus vs Infusion Thrombolytic Therapy  Journal Articles
• Safety of thrombolysis in cerebral venous thrombosis  Journal Articles
• Safety of thrombolysis in cerebral venous thrombosis A systematic review of the literature  Journal Articles
• Safety, Functional Disability, Healthcare Utilization, and Quality-of-Life Outcomes in Elderly Receiving Alteplase and Tenecteplase: A Secondary Analysis From the AcT Trial.  Journal Articles
• Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer  Journal Articles
• Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE‐HIP1, SAVE‐HIP2 and SAVE‐KNEE  Journal Articles
• Setting a standard for venous thromboembolism prophylaxis  Journal Articles
• Sex differences in the antithrombotic effects of aspirin  Journal Articles
• Sex differences in treatment strategies for pulmonary embolism in older adults: The SERIOUS-PE study of RIETE participants and US Medicare beneficiaries.  Journal Articles
• Sex related differences in platelet function: the effect of aspirin  Journal Articles
• Sex-related differences in the efficacy of acetylsalicylic acid (ASA): The absorption of ASA and its effect on collagen-induced thromboxane B2 generation  Journal Articles
• Should Aspirin Be Discontinued Before Coronary Artery Bypass Surgery?  Journal Articles
• Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?  Journal Articles
• Significant association with location of central venous line placement and risk of venous thrombosis in children  Journal Articles
• Significant variation in mortality and functional outcome after acute ischaemic stroke between western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST)  Journal Articles
• Spontaneous heparin-induced thrombocytopenia syndrome presenting as bilateral adrenal infarction after knee arthroplasty  Journal Articles
• Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: A proposal from the Academic Bleeding Consensus (ABC) Multidisciplinary Working Group  Journal Articles
• State of the Art-A Journey through the World of Antithrombotic Therapy  Journal Articles
• State-of-the-Art-Review : Statins Induce Hypothrombotic States?  Journal Articles
• Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: Findings from the global registry of acute coronary events (GRACE)  Journal Articles
• Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease  Journal Articles
• Stroke and Thromboprophylaxis in the Era of COVID-19  Journal Articles
• Stroke severity, early recovery and outcome are each related with clinical classification of stroke: Data from the ‘Tinzaparin in Acute Ischaemic Stroke Trial’ (TAIST)  Journal Articles
• Stroke‐prevention strategies in North American patients with atrial fibrillation: The GLORIA‐AF registry program  Journal Articles
• Studies on the medical treatment of deep vein thrombosis.  Journal Articles
• Successful Use of Thrombolysis in an Extremely Low Birth Weight, Premature Infant With Aortic Thrombosis  Journal Articles
• Successors to heparin: new antithrombotic agents.  Journal Articles
• Superior mesenteric vein thrombosis after the Whipple procedure: an aggressive, combined treatment approach.  Journal Articles
• Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points  Journal Articles
• Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure  Journal Articles
• Surgical management of submacular hemorrhage: experience at an academic Canadian centre  Journal Articles
• Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies  Journal Articles
• Sustained Benefit 20 Years After Reperfusion Therapy in Acute Myocardial Infarction  Journal Articles
• Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease  Journal Articles
• THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.  Journal Articles
• THE RELATIONSHIP BETWEEN DOSE OF ASPIRIN, SIDE-EFFECTS AND ANTITHROMBOTIC EFFECTIVENESS  Journal Articles
• THROMBOLYTIC THERAPY FOR VENOUS THROMBOEMBOLISM  Journal Articles
• THROMBOLYTIC THERAPY IN NEUROINTENSIVE CARE  Journal Articles
• TREATMENT OF VENOUS THROMBOEMBOLISM  Journal Articles
• Tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis of randomized and non-randomized studies  Journal Articles
• Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial.  Journal Articles
• Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial  Journal Articles
• The Antithrombotic Properties of Human Prothrombin Fragment 1.2 in Mice  Journal Articles
• The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy  Journal Articles
• The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2  Journal Articles
• The Effects of Standard and Low Molecular Weight Heparin on Bone Nodule Formation In Vitro  Journal Articles
• The Evolving Pattern of Symptomatic Coronary Artery Disease in the United States and Canada: Baseline Characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial  Journal Articles
• The Influence of Age on in vitro Plasmin Generation in the Presence of Fibrin Monomer  Journal Articles
• The King is Dead (Warfarin): Direct Thrombin and Factor Xa Inhibitors: The Next Diadochian War?  Journal Articles
• The Perioperative Management of Antithrombotic Therapy  Journal Articles
• The Primary and Secondary Prevention of Coronary Artery Disease  Journal Articles
• The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy  Journal Articles
• The Sixth (2000) ACCP Guidelines for Antithrombotic Therapy for Prevention and Treatment of Thrombosis  Journal Articles
• The association between cancer diagnosis, care, and outcomes in 1 million patients hospitalized for acute pulmonary embolism  Journal Articles
• The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model  Journal Articles
• The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial  Journal Articles
• The consensus report: is it ever the last word?  Journal Articles
• The direct thrombin inhibitor hirudin  Journal Articles
• The effects of apixaban on hospitalizations in patients with different types of atrial fibrillation: insights from the AVERROES trial  Journal Articles
• The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study  Journal Articles
• The emerging role of low-molecular-weight heparin in cardiovascular medicine  Journal Articles
• The evolving role of direct thrombin inhibitors in acute coronary syndromes  Journal Articles
• The evolving role of direct thrombin inhibitors in acute coronary syndromes.  Journal Articles
• The identification of at‐risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH  Journal Articles
• The optimal antithrombotic dose of aspirin  Journal Articles
• The organization to assess strategies for ischemic syndromes (OASIS) pilot study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation  Journal Articles
• The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits  Journal Articles
• The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin  Journal Articles
• The risk of iatrogenic bleeding in acute coronary syndromes and long-term mortality  Journal Articles
• The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial  Journal Articles
• The role of platelets and platelet inhibition in acute myocardial infarction  Journal Articles
• The safety of antithrombotic therapy during pregnancy  Journal Articles
• The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians.  Journal Articles
• The status of new anticoagulants  Journal Articles
• The treatment effect across ASPECTS in acute ischemic stroke: Analysis from the AcT Trial  Journal Articles
• The treatment of venous thromboembolism.  Journal Articles
• The use of alteplase to restore patency of central venous lines in pediatric patients: A cohort study  Journal Articles
• Theoretical and Practical Aspects of Thrombolytic Therapy  Journal Articles
• Therapeutic strategies for thrombosis: new targets and approaches  Journal Articles
• Therapy of deep vein thrombosis.  Journal Articles
• Thrombin and Antithrombotics  Journal Articles
• Thrombin structure and function  Journal Articles
• Thromboembolic Disease and Antithrombotic Therapy in Newborns  Journal Articles
• Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism  Journal Articles
• Thrombolysis Despite Recent Stroke  Journal Articles
• Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction  Conferences
• Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review.  Journal Articles
• Thrombolysis in Pediatric Stroke Study  Journal Articles
• Thrombolysis in Pulmonary Embolism  Journal Articles
• Thrombolysis with a Combination of Small Doses of Streptokinase and Full Doses of Heparin  Journal Articles
• Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances  Journal Articles
• Thrombolytic Therapy  Journal Articles
• Thrombolytic Therapy and Fatal Pulmonary Emboli  Journal Articles
• Thromboprophylaxis in Patients Receiving Chemotherapy  Journal Articles
• Thromboprophylaxis in medical–surgical critically ill patients  Journal Articles
• Thrombosis and anticoagulation.  Journal Articles
• Thrombosis in Children  Journal Articles
• Thrombosis.  Journal Articles
• Timing of the resumption of antithrombotic agents following surgical evacuation of chronic subdural hematomas: a retrospective cohort study  Journal Articles
• Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial  Journal Articles
• Tissue Plasminogen Activator Overdose in Acute Ischemic Stroke Patients Linked to Poorer Functional Outcomes  Journal Articles
• Tranexamic acid in coronary artery surgery: One-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial  Journal Articles
• Transforming the scientific, health care, and sociopolitical culture of an entire country through clinical research: The story of GISSI  Journal Articles
• Transradial Approach for Coronary Angiography and Interventions  Journal Articles
• Treating acute myocardial infarction.  Journal Articles
• Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies  Journal Articles
• Treatment and Prevention of Heparin-Induced Thrombocytopenia  Journal Articles
• Treatment and Prevention of Heparin-Induced Thrombocytopenia  Journal Articles
• Treatment for acute myocardial infarction: Overview of randomized clinical trials  Journal Articles
• Treatment of Deep-Vein Thrombosis  Journal Articles
• Treatment of Venous Thromboembolism  Journal Articles
• Treatment of Venous Thromboembolism  Journal Articles
• Treatment of acute ischemic stroke: from fibrinolysis to neurointervention  Journal Articles
• Treatment with novel oral anticoagulants  Journal Articles
• Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018  Journal Articles
• Trifecta or Triple Threat? The Challenge of Post-PCI Management in Patients Receiving Chronic Oral Anticoagulant Therapy  Journal Articles
• Triple Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Stents  Journal Articles
• Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism  Journal Articles
• Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis  Journal Articles
• Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti‐factor Xa levels  Journal Articles
• Unresolved issues in the use of direct acting oral anticoagulants  Journal Articles
• Unstable Angina and Non–ST-Elevation Myocardial Infarction  Journal Articles
• Unstable angina.  Journal Articles
• Unstable angina.  Journal Articles
• Update on heparin: what do we need to know?  Journal Articles
• Updates in thrombosis in pediatrics: where are we after 20 years?  Journal Articles
• Urgent Clinical Challenges in Children With Ischemic Stroke  Journal Articles
• Urokinase Therapy: Dosage Schedules and Coagulant Side Effects  Journal Articles
• Use of Antithrombotic Agents During Pregnancy  Journal Articles
• Use of Antithrombotic Agents During Pregnancy  Conferences
• Use of Antithrombotic Agents During Pregnancy  Journal Articles
• Use of Antithrombotic Agents During Pregnancy  Journal Articles
• Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study  Journal Articles
• Use of antiplatelets and lipid lowering therapy in patients with peripheral vascular disease undergoing surgery [corrected].  Journal Articles
• Use of antithrombotic agents during pregnancy.  Journal Articles
• Use of antithrombotic agents during pregnancy.  Journal Articles
• Use of novel antithrombotic agents for COVID‐19: Systematic summary of ongoing randomized controlled trials  Journal Articles
• Use of thrombolytic agents to treat neonatal thrombosis in clinical practice  Journal Articles
• Utility of Intravenous Alteplase Prior to Endovascular Stroke Treatment  Journal Articles
• VENOUS THROMBOEMBOLISM ASSOCIATED WITH GYNECOLOGIC SURGERY  Journal Articles
• VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy  Journal Articles
• Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives  Journal Articles
• Varied opinions on thrombolysis for venous thromboembolism in infants and children: Findings from a survey of pediatric hematology–oncology specialists  Journal Articles
• Vascular viewpoint  Journal Articles
• Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014  Journal Articles
• Venous Thromboembolism Prophylaxis in Acutely Ill Hospitalized Medical Patients  Journal Articles
• Venous Thromboembolism in Patients with Chronic Obstructive Pulmonary Disease  Journal Articles
• Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy  Journal Articles
• Venous thromboembolic disease: An observational study in medical-surgical intensive care unit patients  Journal Articles
• Venous thromboembolism and bleeding in a community setting  Journal Articles
• Venous thromboembolism in critical illness in a community intensive care unit  Journal Articles
• Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review  Journal Articles
• Video laparoscopic surgery: is out‐of‐hospital thromboprophylaxis necessary?  Journal Articles
• Vitamin K antagonist reversal strategies: Systematic review and network meta‐analysis from the AABB  Journal Articles
• Vocal cord paralysis secondary to spontaneous internal carotid dissection: Case report and systematic review of the literature  Journal Articles
• Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials  Journal Articles
• What is the role for antithrombotics in cancer care?  Journal Articles
• When to Start Pharmacologic Thromboprophylaxis  Journal Articles
• Which antithrombotic to use during PCI?  Journal Articles
• Women’s values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities  Journal Articles
• [Antithrombotic treatment of atrial fibrillation].  Journal Articles
• introduction: Thrombosis  Journal Articles
• “ISTH guidelines for antithrombotic treatment in COVID‐19”: Reply  Journal Articles
• “Part of the Ritual”: Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome  Journal Articles